Construction of sRNA Regulatory Network for Magnaporthe oryzae Infecting Rice Based on Multi-Omics Data

Studies have shown that fungi cause plant diseases through cross-species RNA interference mechanism (RNAi) and secreted protein infection mechanism. The small RNAs (sRNAs) of Magnaporthe oryzae use the RNAi mechanism of rice to realize the infection process, and different effector proteins can increase the autotoxicity by inhibiting pathogen-associated molecular patterns triggered immunity (PTI) to achieve the purpose of infection. However, the coordination of sRNAs and proteins in the process of M. oryzae infecting rice is still poorly understood. Therefore, the combination of transcriptomics and proteomics to study the mechanism of M. oryzae infecting rice has important theoretical significance and practical value for controlling rice diseases and improving rice yields. In this paper, we used the high-throughput data of various omics before and after the M. oryzae infecting rice to screen differentially expressed genes and sRNAs and predict protein interaction pairs based on the interolog and the domain-domain methods. We were then used to construct a prediction model of the M. oryzae-rice interaction proteins according to the obtained proteins in the proteomic network. Finally, for the differentially expressed genes, differentially expressed sRNAs, the corresponding mRNAs of rice and M. oryzae, and the interacting protein molecules, the M. oryzae-rice sRNA regulatory network was built and analyzed, the core nodes were selected. The functional enrichment analysis was conducted to explore the potential effect pathways and the critical infection factors of M. oryzae sRNAs and proteins were mined and analyzed. The results showed that 22 sRNAs of M. oryzae, 77 secretory proteins of M. oryzae were used as effect factors to participate in the infection process of M. oryzae. And many significantly enriched GO modules were discovered, which were related to the infection mechanism of M. oryzae.

Traveling waves for a nonlocal dispersal SIR epidemic model with the mass action infection mechanism

This paper is concerned with a nonlocal dispersal susceptible–infected–recovered (SIR) epidemic model adopted with the mass action infection mechanism. We mainly study the existence and non-existence of traveling waves connecting the infection-free equilibrium state and the endemic equilibrium state. The main difficulties lie in the fact that the semiflow generated here does not admit the order-preserving property. Meanwhile, this new model brings some new challenges due to the unboundedness of the nonlinear term. We overcome these difficulties to obtain the boundedness of traveling waves with the speed $c>c_{\min}$ by some analysis techniques firstly and then prove the existence of traveling waves by employing Lyapunov–LaSalle theorem and Lebesgue dominated convergence theorem. By utilizing a approximating method, we study the existence of traveling waves with the critical wave speed $c_{\min}$. Our results on this new model may provide some implications on disease modelling and controls.

A Review of SARS-CoV-2, Responsible for COVID-19: History, Biology, Infection Mechanism, Antigenic Vaccines, Their Risks and how an Alternate RBD Vaccine is Safer?

The SARS (severe acute respiratory syndrome)-CoV (Coronavirus)-2 S(spike)-protein mRNA/cDNA currently being used as vaccines are antigenic but not antigens against SARS-CoV-2, that causes COVID (Coronavirus Disease) -19. Furthermore, the mRNA and cDNA antigenic vaccines also have potentials for homologous as well as heterologous recombination, primarily into the somatic cell DNA of the vaccine recipients. On the contrary, a SARS-CoV-2 RBD-protein antigen, a part of the S-protein, will directly stimulate antibody production against SARS-CoV-2. Hence, a vaccine composed of SARS-CoV-2 RBD-protein as a safer, fast acting, and effective vaccine against SARS-CoV-2 and thus against COVID-19. This is also useful for some immune compromised individuals.

A Review of SARS-CoV-2, Responsible for COVID-19: History, Biology, Infection Mechanism, Antigenic Vaccines, their Risks and How an Alternate RBD Vaccine is Safer?

The SARS (severe acute respiratory syndrome)-CoV (Coronavirus)-2 S(spike)-protein mRNA/cDNA currently being used as vaccines are antigenic but not antigens against SARS-CoV-2, that causes COVID (Coronavirus Disease) -19. Furthermore, the mRNA and cDNA antigenic vaccines also have potentials for homologous as well as heterologous recombination, primarily into the somatic cell DNA of the vaccine recipients. On the contrary, a SARS-CoV-2 RBD-protein antigen, a part of the S-protein, will directly stimulate antibody production against SARS-CoV-2. Hence, a vaccine composed of SARS-CoV-2 RBD-protein as a safer, fast acting, and effective vaccine against SARS-CoV-2 and thus against COVID-19. This is also useful for some immune compromised individuals.